Electroconvulsive therapy for the acute management of severe agitation in dementia (ECT-AD): A modified study protocol
Maria I Lapid,Julia Merrill,Martina Mueller,Adriana P Hermida,Louis Nykamp,Jason Andrus,Heela Azizi,Paula Bolton,Nana Bonsu,Raphael Braga,Catherine R Dillon,Donna Ecklesdafer,Darci Evans,David Harper,Hannah Heintz,Sehba Hussain-Krauter,Olivia Holzgen,Daniel Humphrey,Salima Jiwani,Emily K Johnson,Simran Kang,Janelle Kassien,Jonathan Kim,Rebecca G Knapp,Simon Kung,Neil Kremen,Kendra Le,Jack Mahdasian,Taylor Marzouk,Jared D Masrud,Jefferson Mattingly,Dawn Miller,Sandeep R Pagali,Regan Patrick,Patricio Riva Posse,Cristina Pritchett,Aniqa Rahman,Swapnil Rath,Cara Roczniak,Teresa A Rummans,Sohag Sanghani,Steve Seiner,LeAnn Smart,Evan Tomaschek,Valeriya Tsygankova,Lori VanderSchuur-White,Monica P Walton,James Wilkins,April Williams,Sarah M Williams,George Petrides,Brent P Forester
DOI: https://doi.org/10.1371/journal.pone.0303894
IF: 3.7
2024-06-28
PLoS ONE
Abstract:Objective: This study began as a single-blind randomized controlled trial (RCT) to investigate the efficacy and safety of electroconvulsive therapy (ECT) for severe treatment-refractory agitation in advanced dementia. The aims are to assess agitation reduction using the Cohen-Mansfield Agitation Inventory (CMAI), evaluate tolerability and safety outcomes, and explore the long-term stability of agitation reduction and global functioning. Due to challenges encountered during implementation, including recruitment obstacles and operational difficulties, the study design was modified to an open-label format and other protocol amendments were implemented. Methods: Initially, the RCT randomized participants 1:1 to either ECT plus usual care or simulated ECT plus usual care (S-ECT) groups. As patients were enrolled, data were collected from both ECT and simulated ECT (S-ECT) patients. The study now continues in an open-label study design where all patients receive actual ECT, reducing the targeted sample size from 200 to 50 participants. Results: Study is ongoing and open to enrollment. Conclusion: The transition of the ECT-AD study design from an RCT to open-label design exemplifies adaptive research methodologies in response to real-world challenges. Data from both the RCT and open-label phases of the study will provide a unique perspective on the role of ECT in managing severe treatment-refractory agitation in dementia, potentially influencing future clinical practices and research approaches.